CHADS2-VASc Score Calculator
Calculate CHA2DS2-VASc score for atrial fibrillation stroke risk
Embed CHADS2-VASc Score Calculator ▾
Add this tool to your website or blog for free. Includes a small "Powered by ToolWard" bar. Pro users can remove branding.
<iframe src="https://toolward.com/tool/chads2-vasc-score-calculator?embed=1" width="100%" height="500" frameborder="0" style="border:1px solid #e2e8f0;border-radius:12px"></iframe>
Community Tips 0 ▾
No tips yet. Be the first to share!
Compare with similar tools ▾
| Tool Name | Rating | Reviews | AI | Category |
|---|---|---|---|---|
| CHADS2-VASc Score Calculator Current | 4.5 | 2414 | - | Medical Diagnostics Reference |
| MELD Score Liver Failure | 4.8 | 3581 | - | Medical Diagnostics Reference |
| QTc Interval Calculator | 4.7 | 1404 | - | Medical Diagnostics Reference |
| Neonatal Gestational Age | 4.6 | 2260 | - | Medical Diagnostics Reference |
| ABCD2 TIA Risk Score | 4.3 | 2346 | - | Medical Diagnostics Reference |
| Glasgow Coma Scale Calculator | 4.0 | 2816 | - | Medical Diagnostics Reference |
About CHADS2-VASc Score Calculator
Calculate Stroke Risk in Atrial Fibrillation
Atrial fibrillation affects millions of people worldwide and carries a five-fold increased risk of ischaemic stroke. Deciding which patients need anticoagulation therapy - and accepting the associated bleeding risk - is one of the most common clinical decisions in cardiology and general practice. The CHADS2-VASc Score Calculator provides the gold-standard risk stratification tool that guidelines worldwide recommend for making this critical decision.
The CHA2DS2-VASc score improved upon the original CHADS2 score by adding vascular disease, age 65-74, and female sex as risk factors. This refinement better identifies truly low-risk patients who can safely avoid anticoagulation, reducing both unnecessary treatment and the risk of bleeding complications in patients who don't need blood thinners.
How to Calculate the CHA2DS2-VASc Score
Assess each risk factor. C - Congestive heart failure (or LV ejection fraction 40% or less): 1 point. H - Hypertension: 1 point. A2 - Age 75 or older: 2 points. D - Diabetes mellitus: 1 point. S2 - Stroke, TIA, or thromboembolism history: 2 points. V - Vascular disease (prior MI, peripheral artery disease, or aortic plaque): 1 point. A - Age 65-74: 1 point. Sc - Sex category (female): 1 point.
The maximum score is 9. The calculator displays the total score alongside the estimated annual stroke risk and the guideline-recommended anticoagulation strategy. A score of 0 in males (or 1 in females, where the sex point alone doesn't count) suggests anticoagulation may be unnecessary. A score of 1 in males warrants consideration of anticoagulation. Scores of 2 or more clearly indicate anticoagulation is recommended.
Who Relies on This Score?
Cardiologists managing atrial fibrillation patients use CHA2DS2-VASc at every visit to reassess stroke risk as patients age or develop new comorbidities. General practitioners managing the vast majority of AF patients in the community use it to initiate and monitor anticoagulation decisions. Pharmacists verifying anticoagulation appropriateness reference the score regularly.
The CHADS2-VASc Score Calculator is also essential for medical students and trainees who need to understand the evidence-based approach to anticoagulation in atrial fibrillation - a topic that appears on virtually every cardiology examination.
Pairing With HAS-BLED
The CHA2DS2-VASc score tells you the stroke risk, but bleeding risk must also be considered before starting anticoagulation. Guidelines recommend calculating both CHA2DS2-VASc and HAS-BLED scores together. A high HAS-BLED score does not contraindicate anticoagulation - rather, it highlights patients who need closer monitoring and attention to modifiable bleeding risk factors.
Key Clinical Points
The female sex category point was designed to reflect the higher stroke risk in women with AF, but a woman with no other risk factors (score of 1 from sex alone) is still considered low risk. Reassess the score annually and whenever clinical status changes - a patient who was low risk at age 63 crosses a threshold at age 65. Direct oral anticoagulants have largely replaced warfarin for most patients, but the decision to anticoagulate still starts with CHA2DS2-VASc.